At the third China International Supply Chain Expo, biotech and pharmaceutical companies unveiled innovative 'modular' supply chain strategies designed to streamline global operations. These adaptable frameworks, likened to building blocks, allow firms to rapidly adjust production and distribution in response to market demands while maintaining cost efficiency.
Modules are engineered for specialization, with separate units handling raw material sourcing, manufacturing, quality control, and logistics. This approach enables suppliers to collaborate across borders without overhauling entire systems. For clients, it translates to faster delivery of life-saving drugs and medical technologies, particularly in emerging markets.
"Modular systems let us partner with local manufacturers while maintaining global standards," explained a representative from a Shanghai-based biotech firm. "During the pandemic, this flexibility helped us deliver vaccines to 15 countries within six weeks."
The expo highlighted how these models strengthen cross-border collaboration, with participating companies from over 50 countries and regions exploring partnerships. Analysts note that modular chains could reduce medication costs by up to 30% in developing Asian markets through localized production modules.
